Ashe Gena L 4

What Happened
Ashe Gena L, Chief Legal Officer & Corporate Secretary of Anterix, was granted a total of 21,147 contingent awards on May 20, 2026: 3,694 restricted stock units (RSUs) and 17,453 derivative option-type awards. Both grants were reported as acquisitions at $0.00 (no cash paid). These are compensation awards, not open-market purchases or sales.

Key Details

• Transaction date: 2026-05-20; Filing date (Form 4): 2026-05-22 (timely—within the typical 2-business-day reporting window).
• Items granted: 3,694 RSUs (Footnote F1) and 17,453 derivative/option shares (Footnote F2). Reported price: $0.00; reported total cash value at grant: $0.
• Vesting schedule (both grants): 3-year vesting with 1/3 vesting on May 20, 2027, then 1/12 vesting quarterly on Aug 10, Nov 10, Feb 10 and May 20 each year through May 20, 2029.
• Shares owned after the transaction: not specified in the provided filing details.
• Transaction code: A = Award/Grant. No 10b5-1 plan or tax-withholding sale noted in the provided footnotes.

Context

• RSUs: each RSU represents the contingent right to one share of common stock upon vesting (no immediate shares issued).
• Derivative/option awards: these award rights that vest over time and may become exercisable per the stated schedule; they are not an immediate exercise or cashless sale.
• These awards are routine compensation/retention grants and do not by themselves indicate a purchase or sale sentiment.